COVIRAN vaccine starts efficacy tests after proving safe
Yusef Jalali
Press TV, Tehran
Among the eight viable vaccine candidates in Iran, COVIRAN is inching closer to the market.
Produced by the Headquarters for executing Imam Khomeini's Order, COVIRAN kickstarted the second and third human trial phases at the same time on Monday.
Volunteers say they feel proud to be part of this great endeavor for humanity.
The vaccine wrapped up its first phase a month ago.
Phase 1 sought to test whether or not the vaccine is safe to be injected to everyone.
Now the second phase will assess the efficacy of the vaccine against the virus.
As the virus keeps mutating to more lethal forms, COVIRAN experts are certain that the Iranian vaccine is effective at least against the British version of the virus.
Iran is working on seven other homegrown vaccines, including COV-PARS, which is now undergoing the first phase of the human trials.
This as the country has already started mass vaccination, mainly using Russia's Sputnik V.
The question of how much immunity COVIRAN will make will only be answered once the second stage is over. Meanwhile, developers say they have already kicked off mass production of the vaccine to catch up with the country's plan to base its national vaccination program on a domestic vaccine.
Massacre in Pakistan’s Parachinar sparks outrage
IAEA's loss of opportunity to revive diplomacy after new anti-Iran resolution
Pro-Palestine solidarity campaigns facing repression in India
Israel launches air strikes on Syria-Lebanon border crossing
Russia: Comprehensive deal with Iran will include defense, security ties
VIDEO | Israeli embassy shooting in Jordan leaves gunman dead, 3 police injured
VIDEO | Paris march in support of Palestine women
VIDEO | ICC issues arrest warrants for Israeli prime minister, ousted regime war minister
120 Palestinians perish as Israeli war machine keeps ravaging Gaza
VIDEO | Struggles of Palestinian women amidst war, displacement
VIDEO | Hezbollah rains attack drones down on elite Israeli brigade
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
